3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Neurofibromatosis 1
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Lymphoma
1
Lung Neoplasms
1
Leukemia, Myelomonocytic, Juvenile
1
Hematologic Neoplasms
1
Glioma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Hepatocellular
1
Breast Neoplasms
1
Interventions
Radiosurgery
9
Temozolomide
8
Magnetic Resonance Spectroscopy
5
pembrolizumab
4
Specimen Handling
4
Nivolumab
4
Bevacizumab
4
Receptors, Interleukin-8B
3
Memantine
3
trastuzumab deruxtecan
2
abemaciclib
2
Watchful Waiting
2
Surveys and Questionnaires
2
Radiotherapy
2
Radiation
2
Mental Status and Dementia Tests
2
Ipilimumab
2
Biopsy
2
sotorasib
1
sapanisertib
1
sacituzumab govitecan
1
ribociclib
1
pertuzumab
1
osimertinib
1
lenvatinib
1
fluciclovine F-18
1
entrectinib
1
elacestrant
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Brain Neoplasms
×
omipalisib
×
30 days
×
Clear all
No trials found.